HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Recruiting · NCT06369831 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011 | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-06-02 | NCT06369831 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abscint NV/SA | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Delta CHIREC | Brussels | Belgium | 1 |
| Cliniques Universitaires Saint-Luc | Brussels | Belgium | 1 |
| Free University Brussels (VUB) | Brussels | Belgium | 1 |
| Institut Jules Bordet | Brussels | Belgium | 2 |
| Medizinische Universität Innsbruck | Innsbruck | Austria | 2 |
| OLV Aalst | Aalst | Belgium | 2 |
| University Hospital Gasthuisberg | Leuven | Belgium | 1 |